| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = -$86,503 ) |
| 2025 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01AI133673 | Maximising Cure Potential in Paediatric HIV Infection | 000 | 5 | NIH | 10/1/2024 | -$86,503 |
|
| Issue Date FY: 2024 ( Subtotal = $3,116,013 ) |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 001 | 3 | NIH | 6/11/2024 | $263,966 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R21AI184080 | Correlative cryoET of the HIV-1 integration targeting in native T-lymphocytes | 000 | 1 | NIH | 2/26/2024 | $131,220 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 21 | NIH | 5/16/2024 | $207,399 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | OT2CA297644 | PROTECT - Harnessing PROTEin degradation for Advanced Childhood Tumors | 000 | 1 | NIH | 6/14/2024 | $101,568 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 001 | 3 | NIH | 6/11/2024 | $263,966 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R21AI184080 | Correlative cryoET of the HIV-1 integration targeting in native T-lymphocytes | 001 | 1 | NIH | 9/11/2024 | $14,580 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI165321 | Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia | 000 | 2 | NIH | 8/23/2024 | $1,045,386 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH129751 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder | 003 | 3 | NIH | 7/5/2024 | $26,867 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH122681 | 2/2 - Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development | 000 | 4 | NIH | 8/16/2024 | $439,038 |
| 2024 | 2024 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH129751 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder | 002 | 3 | NIH | 12/20/2023 | $241,807 |
| 2024 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 12/11/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH129751 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder | 001 | 2 | NIH | 10/26/2023 | $380,216 |
| 2024 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 12/11/2023 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORD | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 07 | 1 | CDC | 9/3/2024 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 06 | 1 | CDC | 2/16/2024 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 06 | 1 | CDC | 2/16/2024 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORD | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 08 | 1 | CDC | 9/12/2024 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORD | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 08 | 1 | CDC | 9/12/2024 | $0 |
| 2024 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORD | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 07 | 1 | CDC | 9/3/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,932,896 ) |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH122681 | 2/2 - Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development | 001 | 3 | NIH | 8/11/2023 | $413,309 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 7/31/2023 | $267,045 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 2 | NIH | 7/31/2023 | $267,045 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH122681 | 2/2 - Identification and Validation of Expression Quantitative Trait Loci (eQTLs) in discrete cell types across human brain development | 000 | 3 | NIH | 7/17/2023 | $445,168 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 000 | 20 | NIH | 5/3/2023 | $252,399 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | R01MH129751 | 4/4 - The Autism Sequencing Consortium: Discovering autism risk genes and how they impact core features of the disorder | 001 | 2 | NIH | 5/23/2023 | $269,341 |
| 2023 | 2023 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | U01AI165321 | Optimizing the dose of tafenoquine for the radical cure of Plasmodium vivax malaria in Southeast Asia | 000 | 1 | NIH | 9/8/2023 | $1,067,899 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 05 | 1 | CDC | 8/14/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 05 | 1 | CDC | 8/14/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 02 | 1 | CDC | 12/23/2022 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 02 | 1 | CDC | 12/23/2022 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 04 | 1 | CDC | 3/10/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 04 | 1 | CDC | 3/10/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 03 | 1 | CDC | 1/12/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 03 | 1 | CDC | 1/12/2023 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 01 | 1 | CDC | 10/24/2022 | $0 |
| 2023 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 01 | 1 | CDC | 10/24/2022 | $0 |
| 2023 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 001 | 3 | NIH | 11/23/2022 | -$44,436 |
| 2023 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 2 | NIH | 11/23/2022 | -$363 |
| 2023 | 2020 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | | | | GBR | F32CA239339 | HORMAD1 directs the assembly of a meiotic-Shieldin complex in meiosis and cancer | 000 | 2 | NIH | 11/23/2022 | -$4,510 |
|
| Issue Date FY: 2022 ( Subtotal = $1,266,251 ) (Continued on the next page) |
| 2022 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 00 | 1 | CDC | 8/19/2022 | $200,000 |
| 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 1 | NIH | 6/17/2022 | $272,913 |
| 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AI168655 | Impact of immune sex differences in the first 1000 days of life and in childhood and adolescence | 000 | 1 | NIH | 6/17/2022 | $272,912 |
| 2022 | 2022 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | U01AA014809 | Defining Translational Approaches for the Image-based Detection of Prenatal Alcohol Exposure | 001 | 19 | NIH | 8/15/2022 | $239,399 |
| 2022 | 2022 | UNIVERSITY OF OXFORD | University Offices | OXFORD | province | | | GBR | U01GH002332 | Effectiveness of Covid-19 vaccine booster in Indonesia | 00 | 1 | CDC | 8/19/2022 | $449,989 |
| 2022 | 2021 | UNIVERSITY OF OXFORD | UNIVERSITY OFFICES | OXFORD | OXFORDSHIRE | | | GBR | F32DC017637 | Structural and functional connectivity markers of developmental speech and language disorders | 000 | 3 | NIH | 8/3/2022 | -$28,356 |
|